Showing results 1 to 20 of 26
next >
| Issue Date | Title | Author(s) |
| 2-Nov-2023 | Blood Basophil Concentration at Diagnosis Corelates with Prognosis in Newly-Diagnosed Persons with Chronic Myeloid Leukaemia | Vrablova, Lucia; Zhang, Xiaoshuai; Kriegova, Eva; Kudelka, Milos; Radvansky, Martin; Yang, Sen; Juranova, Jaroslava; Papajik, Tomas; Gale, Robert Peter; Jiang, Qian; Faber, Edgar |
| 5-Nov-2024 | Bone Marrow Endothelial Progenitor Cells Are Involved in Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia | Yu, Shunjie; Yuan, Mengyao; Bao, Mei; Zhang, Xiaoshuai; Jiang, Qian |
| 1-Dec-2021 | Bridging the Gap Between Computational Photography and Visual Recognition | VidalMata, Rosaura G.; Banerjee, Sreya; RichardWebster, Brandon; Albright, Michael; Davalos, Pedro; McCloskey, Scott; Miller, Ben; Tambo, Asong; Ghosh, Sushobhan; Nagesh, Sudarshan; Yuan, Ye; Hu, Yueyu; Wu, Junru; Yang, Wenhan; Zhang, Xiaoshuai; Liu, Jiaying; Wang, Zhangyang; Chen, Hwann-Tzong; Huang, Tzu-Wei; Chin, Wen-Chi; Li, Yi-Chun; Lababidi, Mahmoud; Otto, Charles; Scheirer, Walter J. |
| 15-Nov-2022 | Cancer-Related Gene Mutations Drive Resistance to the Third-Generation Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia | Zhang, Xiaoshuai; Li, Zongru; Qin, Ya-Zhen; Gale, Robert Peter; Lai, Yueyun; Shi, Hongxia; Huang, Xiao Jun; Jiang, Qian |
| 2020 | A Comprehensive Benchmark for Single Image Compression Artifact Reduction | Liu, Jiaying; Liu, Dong; Yang, Wenhan; Xia, Sifeng; Zhang, Xiaoshuai; Dai, Yuanying |
| 23-Nov-2021 | Correlations between Mutations in Cancer -Related Genes, Therapy Responses and Outcomes of the 3 (rd) Generation Tyrosine Kinase-Inhibitor (TKI) in Persons with Chronic Myeloid Leukemia Failing Prior TKI-Therapy | Zhang, Xiaoshuai; Li, Zongru; Qin, Yazhen; Gale, Robert Peter; Huang, Xiaojun; Jiang, Qian |
| 2018 | DMCNN: DUAL-DOMAIN MULTI-SCALE CONVOLUTIONAL NEURAL NETWORK FOR COMPRESSION ARTIFACTS REMOVAL | Zhang, Xiaoshuai; Yang, Wenhan; Hu, Yueyu; Liu, Jiaying |
| 2023 | External validation of the predictive scoring systems for molecular responses in chronic myeloid leukaemia receiving initial imatinib-therapy | Qi, Feiyang; Zhang, Xiaoshuai; Gale, Robert Peter; Liu, Bingcheng; Huang, Jian; Huang, Xiaojun; Jiang, Qian |
| 5-Nov-2024 | High-Risk "Failure" Events Predicting Worse Survival in Patients with Chronic Myeloid Leukemia during Tyrosine Kinase Inhibitor Therapy | Zhang, Xiaoshuai; Qi, Feiyang; Gao, Hanlin; Yang, Sen; Jiang, Qian |
| 2019 | How You Act Tells a Lot: Privacy-Leaking Attack on Deep Reinforcement Learning | Pan, Xinlei; Wang, Weiyao; Zhang, Xiaoshuai; Li, Bo; Yi, Jinfeng; Song, Dawn |
| May-2023 | Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase | Yang, Sen; Zhang, Xiaoshuai; Gale, Robert Peter; Du, Xin; Chen, Chun-yan; Weng, Jian-yu; Huang, Jian; Li, Fei; Zeng, Yun; Xiao, Zhen; Hu, Jian-da; Yang, Li-jie; Liu, Zhuo-gang; Li, Guo-hui; Sun, Xiu-li; Yang, Wei; Feng, Ru; Han, Yan-qiu; Jing, Yu; Xu, Na; Liu, Xiao-li; Liu, Zhen-fang; Wang, Xiao-dong; Wu, Shi-xin; Liang, Rong; Zhang, Yan-li; Yang, Yun-fan; Zhu, Huan-ling; Pan, Ling; Meng, Li; Zhao, Yan-hong; Yi, Hai; Liu, Yi-lan; Zhang, Wei-hua; Zheng, Yuan-jun; Zhou, Ze-ping; Chen, Su-ning; Qiu, Hui-ying; Li, Wei-ming; Jia, Zhi-lin; Bai, Yan-liang; Lin, Li-e; Liu, Bing-cheng; Liu, Chun-shui; Luo, Jian-min; Meng, Jun-xia; Sun, Zhi-qiang; Zhang, Yan-qing; Huang, Xiao-jun; Jiang, Qian |
| 15-Nov-2022 | Is the 2nd Generation Tyrosine Kinase-Inhibitor a Better Initial Therapy Than Imatinib in Persons with Chronic Myeloid Leukemia Presenting in Accelerated Phase: A Multicenter Retrospective Study | Yang, Sen; Zhang, Xiaoshuai; Zhang, Yanli; Du, Xin; Weng, Jianyu; Zhu, Huanling; Pan, Ling; Yang, Yun-fan; Meng, Li; Liu, Zhenfang; Liu, Xiaoli; Xu, Na; Chen, Chunyan; Wang, Xiaodong; Liang, Rong; Huang, Jian; Li, Guohui; Liu, Chunshui; Lin, Hai; Hu, Jianda; Fei, Li; Liu, Bingcheng; Li, Weiming; Liu, Zhuogang; Yang, Wei; Huang, Xiao Jun; Jiang, Qian |
| 2-Nov-2023 | Is the Prognosis of People with Chronic Myeloid Leukaemia Presenting in Accelerated Phase Always Worse Compared with People Presenting in Chronic Phase? | Yang, Sen; Zhang, Xiaoshuai; Zhang, Mengyu; Gale, Robert Peter; Huang, Xiao Jun; Jiang, Qian |
| 4-Dec-2024 | Is there really an accelerated phase of chronic myeloid leukaemia at presentation? | Yang, Sen; Zhang, Xiaoshuai; Gale, Robert Peter; Huang, Xiaojun; Jiang, Qian |
| Apr-2025 | Multidimensional Directionality-Enhanced Segmentation via large vision model | Huang, Xingru; Yue, Changpeng; Guo, Yihao; Huang, Jian; Jiang, Zhengyao; Wang, Mingkuan; Xu, Zhaoyang; Zhang, Guangyuan; Liu, Jin; Zhang, Tianyun; Zheng, Zhiwen; Zhang, Xiaoshuai; He, Hong; Jiang, Shaowei; Sun, Yaoqi |
| 5-Nov-2024 | Olverembatinib 30 Mg Versus 40 Mg Every Other Day (QOD) in Patients with Tyrosine Kinase Inhibitor (TKI) Resistant or Intolerant Chronic-Phase Chronic Myeloid Leukemia (CML-CP): A Multi-Center Propensity Score-Matched Analysis | Zhang, Xiaoshuai; Yu, Lu; Zhou, Li; Zhang, Yanli; Zhu, Huanling; Liu, Bingcheng; Du, Xin; Wang, Xiaodong; Yang, Linhua; Ma, Yanping; Meng, Li; Zhang, Yanqing; Li, Guohui; Yang, Lijie; Wang, Baohong; Ran, Xuehong; Huang, Jian; Wen, Qin; Wen, Yan; Md, Yuxia Zhao; Md, Yu Zhu; Han, Yanqiu; Md, Zhenfang Liu; Weng, Jianyu; Jiang, Qian |
| Dec-2025 | Optimizing olverembatinib dose in chronic phase chronic myeloid leukemia | Zhang, Xiaoshuai; Yang, Yunfan; Liu, Bingcheng; Du, Xin; Wang, Xiaodong; Zhu, Huanling; Yu, Lu; Li, Zongru; Zhao, Shasha; Yang, Linhua; Ma, Yanping; Meng, Li; Zhang, Yanqing; Li, Guohui; Yang, Lijie; Wang, Baohong; Ran, Xuehong; Huang, Jian; Gao, Na; Wen, Qin; Wen, Yan; Zhao, Yuxia; Zhu, Yu; Han, Yanqiu; Liu, Zhenfang; Weng, Jianyu; Gale, Robert Peter; Zhou, Li; Zhang, Yanli; Jiang, Qian |
| 2023 | Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era | Qi, Feiyang; Bao, Mei; Gao, Hanlin; Zhang, Xiaoshuai; Zhao, Shasha; Wang, Chenglei; Li, Wenwen; Jiang, Qian |
| 31-Oct-2024 | A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy | Zhang, Xiaoshuai; Liu, Bingcheng; Huang, Jian; Zhang, Yanli; Xu, Na; Gale, Robert Peter; Li, Weiming; Liu, Xiaoli; Zhu, Huanling; Pan, Ling; Yang, Yunfan; Lin, Hai; Du, Xin; Liang, Rong; Chen, Chunyan; Wang, Xiaodong; Li, Guohui; Liu, Zhuogang; Zhang, Yanqing; Liu, Zhenfang; Hu, Jianda; Liu, Chunshui; Li, Fei; Yang, Wei; Meng, Li; Han, Yanqiu; Lin, Li'e; Zhao, Zhenyu; Tu, Chuanqing; Zheng, Caifeng; Bai, Yanliang; Zhou, Zeping; Chen, Suning; Qiu, Huiying; Yang, Lijie; Sun, Xiuli; Sun, Hui; Zhou, Li; Liu, Zelin; Wang, Danyu; Guo, Jianxin; Pang, Liping; Zeng, Qingshu; Suo, Xiaohui; Zhang, Weihua; Zheng, Yuanjun; Huang, Xiaojun; Jiang, Qian |
| 23-Nov-2021 | A Predictive Score for Failure-Free Survival in Persons with Chronic Myeloid Leukemia Receiving Imatinib | Zhang, Xiaoshuai; Huang, Xiaojun; Gale, Robert Peter; Jiang, Qian |
